<unk> (aerosol) is a corticosteroid that is FDA approved for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp.   Common adverse reactions include paresthesia, pruritus, acne, alopecia, conjunctivitis, irritation, dryness, folliculitis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, skin atrophy, striae, and miliaria.
Betamethasone valerate 
Chloroxylenol
Dimetofrine
Hydrocortisone aceponate
Dexamethasone 
Hydrocortisone butyrate
Hydrocortisone buteprate
Demoxytocin